IPO Aftermarket: Biotech dominates Q1

With only six IPOs, Q1 ranks as the lowest quarter for VC-backed IPOs since Q3 of 2011

5 April 2016•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.